Escaping PTAB Review Through Strategic Disclaimer in CBM Proceedings -
A patent is only eligible for covered business method (CBM) review if it: (1) claims a method or apparatus for performing data processing or other...more
On January 9, 2017, the U.S. Court of Appeals for the Federal Circuit issued a decision in Phigenix, Inc. v. Immunogen, Inc. dismissing an appeal by a petitioner from the Patent Trial and Appeal Board (PTAB) for lack of...more
On March 27, 2015, the U.S. Patent and Trademark Office (USPTO) announced the first of three upcoming "rule packages" that will clarify and modify rules for proceedings under the America Invents Act (AIA). In a blog post on...more